.
  • NIFTY 25,342.75 +167.35 (+0.66%)
  • SENSEX 82,344.68 +487.20 (+0.60%)
 
BSE
NSE

Wednesday, January 28, 2026 , BSE Sensex : 82,344.68 82,344.68(0.60%) , Adani Ports : 1,381.60 1,381.60(1.28%) , Asian Paints : 2,510.85 2,510.85(-4.34%) , Axis Bank : 1,320.50 1,320.50(0.46%) , Bajaj Finance : 935.15 935.15(2.20%) , Bajaj Finserv : 1,941.10 1,941.10(1.33%) , Bharat Electron : 453.40 453.40(8.90%) , Bharti Airtel : 1,957.05 1,957.05(-0.74%) , Eternal : 266.45 266.45(5.09%) , HCL Technologies : 1,730.40 1,730.40(0.61%) , HDFC Bank : 932.65 932.65(0.63%) , Hind. Unilever : 2,380.35 2,380.35(-0.83%) , ICICI Bank : 1,367.40 1,367.40(0.30%) , Infosys : 1,666.40 1,666.40(-1.01%) , Interglobe Aviat : 4,748.45 4,748.45(-0.44%) , ITC : 321.25 321.25(0.77%) , Kotak Mah. Bank : 412.40 412.40(0.84%) , Larsen & Toubro : 3,793.65 3,793.65(0.10%) , M & M : 3,448.65 3,448.65(1.60%) , Maruti Suzuki : 14,876.80 14,876.80(-2.39%) , NTPC : 348.20 348.20(0.88%) , Power Grid Corpn : 259.75 259.75(2.10%) , Reliance Industr : 1,397.05 1,397.05(1.16%) , SBI : 1,062.80 1,062.80(0.94%) , Sun Pharma.Inds. : 1,610.15 1,610.15(-1.78%) , Tata Steel : 193.80 193.80(0.68%) , TCS : 3,199.85 3,199.85(1.31%) , Tech Mahindra : 1,762.45 1,762.45(0.99%) , Titan Company : 3,976.70 3,976.70(-0.50%) , Trent : 3,863.30 3,863.30(1.91%) , UltraTech Cem. : 12,769.25 12,769.25(1.41%) ,

Nifty 50 : 25,342.75 167.35(0.66%) , Adani Enterp. : 1,994.70 35.20(1.80%) , Adani Ports : 1,381.90 18.00(1.32%) , Apollo Hospitals : 6,877.50 84.00(1.24%) , Asian Paints : 2,511.80 -111.00(-4.23%) , Axis Bank : 1,319.80 4.00(0.30%) , Bajaj Auto : 9,433.50 -58.50(-0.62%) , Bajaj Finance : 935.15 20.45(2.24%) , Bajaj Finserv : 1,940.30 22.60(1.18%) , Bharat Electron : 453.00 37.05(8.91%) , Bharti Airtel : 1,957.70 -15.70(-0.80%) , Cipla : 1,328.40 15.40(1.17%) , Coal India : 444.05 21.15(5.00%) , Dr Reddy's Labs : 1,222.50 -17.30(-1.40%) , Eicher Motors : 7,071.00 -93.50(-1.31%) , Eternal : 266.30 12.45(4.90%) , Grasim Inds : 2,839.10 -17.10(-0.60%) , HCL Technologies : 1,729.60 9.40(0.55%) , HDFC Bank : 932.70 6.30(0.68%) , HDFC Life Insur. : 728.60 8.55(1.19%) , Hind. Unilever : 2,378.40 -22.50(-0.94%) , Hindalco Inds. : 998.20 36.35(3.78%) , ICICI Bank : 1,367.70 6.30(0.46%) , Infosys : 1,666.50 -16.20(-0.96%) , Interglobe Aviat : 4,749.00 -20.00(-0.42%) , ITC : 321.15 2.50(0.78%) , Jio Financial : 255.20 -0.85(-0.33%) , JSW Steel : 1,218.70 -3.30(-0.27%) , Kotak Mah. Bank : 412.40 3.70(0.91%) , Larsen & Toubro : 3,794.00 6.20(0.16%) , M & M : 3,449.20 55.70(1.64%) , Maruti Suzuki : 14,877.00 -368.00(-2.41%) , Max Healthcare : 958.60 -16.90(-1.73%) , Nestle India : 1,292.40 -10.90(-0.84%) , NTPC : 348.05 3.35(0.97%) , O N G C : 268.58 20.63(8.32%) , Power Grid Corpn : 259.80 5.45(2.14%) , Reliance Industr : 1,396.70 16.20(1.17%) , SBI : 1,063.50 10.35(0.98%) , SBI Life Insuran : 2,053.20 15.00(0.74%) , Shriram Finance : 1,018.80 17.75(1.77%) , Sun Pharma.Inds. : 1,610.60 -28.30(-1.73%) , Tata Consumer : 1,131.80 -55.60(-4.68%) , Tata Motors PVeh : 340.45 -0.10(-0.03%) , Tata Steel : 193.85 1.57(0.82%) , TCS : 3,200.10 42.10(1.33%) , Tech Mahindra : 1,762.90 17.80(1.02%) , Titan Company : 3,975.20 -21.80(-0.55%) , Trent : 3,864.00 68.90(1.82%) , UltraTech Cem. : 12,767.00 178.00(1.41%) , Wipro : 237.35 2.55(1.09%) , Wednesday, January 28, 2026

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
12-Jan-2026     13:46
Alembic Pharma receives USFDA tentative approval for Bosutinib Tablets
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Bosulif Tablets, 400 mg, of PF Prism C.V. Bosutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic-phase Philadelphia chromosome'positive (Ph+) chronic myelogenous leukemia (CML), including newly diagnosed patients as well as those resistant or intolerant to prior therapy. It is also indicated for adult patients with accelerated- or blast-phase Ph+ CML who are resistant or intolerant to earlier treatment.

Alembic had earlier received final approvals for Bosutinib Tablets in 100 mg and 500 mg strengths. The 400 mg strength has an estimated market size of about $251 million for the 12 months ended September 2025, according to IQVIA.

With this approval, Alembic's cumulative ANDA approvals from the USFDA stand at 232, comprising 212 final approvals and 20 tentative approvals.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company engaged in the manufacture and marketing of generic pharmaceutical products across global markets.

The company's consolidated net profit jumped 20.40% to Rs 184.71 crore in Q2 FY26, compared to Rs 153.41 crore posted in Q2 FY25. Revenue from operations grew 15.90% year on year (YoY) to Rs 1,910.15 crore in Q2 September 2025.

Shares of Alembic Pharmaceuticals shed 0.51% to Rs 795.80 on the BSE.

Powered by Capital Market - Live News